Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
65.93B | 56.86B | 61.95B | 71.62B | 60.74B | 50.72B | Gross Profit |
10.74B | 9.80B | 10.50B | 12.05B | 9.77B | 8.36B | EBIT |
2.22B | 2.01B | 2.67B | 3.08B | 2.18B | 1.44B | EBITDA |
3.28B | 3.56B | 4.15B | 4.38B | 3.25B | 2.43B | Net Income Common Stockholders |
1.54B | 1.01B | 1.61B | 2.03B | 1.21B | 718.85M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
4.12B | 3.57B | 4.32B | 3.96B | 3.13B | 3.62B | Total Assets |
44.72B | 38.75B | 38.92B | 44.51B | 37.99B | 32.13B | Total Debt |
3.98B | 3.96B | 4.36B | 5.93B | 4.42B | 6.44B | Net Debt |
46.87M | 401.86M | 109.27M | 2.00B | 1.35B | 2.89B | Total Liabilities |
38.58B | 32.67B | 32.87B | 39.12B | 34.38B | 28.07B | Stockholders Equity |
5.03B | 5.58B | 5.59B | 4.99B | 3.56B | 4.19B |
Cash Flow | Free Cash Flow | ||||
1.96B | 725.09M | 1.22B | 2.79B | 2.81B | 1.26B | Operating Cash Flow |
2.70B | 2.01B | 2.80B | 4.08B | 3.65B | 2.21B | Investing Cash Flow |
-1.17B | -1.28B | -1.92B | -1.50B | -975.90M | -956.95M | Financing Cash Flow |
-923.43M | -1.34B | -413.78M | -1.76B | -3.23B | -238.49M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $14.13B | 8.77 | 27.60% | 4.30% | 18.43% | 71.68% | |
70 Outperform | $18.20B | 16.32 | 114.33% | 2.43% | 5.46% | 23.49% | |
68 Neutral | $13.97B | 9.58 | 13.99% | ― | 38.59% | ― | |
66 Neutral | $66.22B | 14.80 | -179.12% | 1.88% | 7.84% | 42.63% | |
66 Neutral | $17.51B | 15.20 | -109.27% | 3.42% | 24.17% | ― | |
63 Neutral | $23.88B | 9.10 | 84.33% | 4.46% | 1.03% | -18.56% | |
59 Neutral | $10.74B | 10.21 | -6.69% | 3.04% | 7.44% | -10.92% |